database > company
Innovia
12415 SouthWest 136 Avenue, Unit 3
Miami, FL 33186 USA
phone:(305) 378-2651
fax:(305) 378-2652
Symbol private
Founded 2002
Employees
          www.innovia-llc.com
Research Sector
Summary Description
It specializes in the development and manufacture of novel biomaterials and innovative medical devices made therefrom. The company is structured such that the biomaterial intellectual property and know-how is owned by Innovia,
Management
Leonard Pinchuk, Ph.D., D.Sc., President/CEO, Co-Founder; John B. Martin, Chief Engineer, Co-Founder; Bruce A. Weber, MBA, Vice President, Clinical, Regulatory and Quality Assurance; Yasushi P. Kato, Ph.D., Vice President, Research and Development
Keywords
novel biomaterials, ophthalmology, cardiovascular, orthopedics, Biomedical Engineering,

Comment | Printable Version | Modify profile Jun. 02, 2009

Description
It specializes in the development and manufacture of novel biomaterials and innovative medical devices made therefrom. The company is structured such that the biomaterial intellectual property and know-how is owned by Innovia, while the medical devices and their related intellectual property and know-how are owned by affiliates of Innovia. Biomaterials can be licensed by Innovia affiliates or other companies while the devices and/or the affiliate housing the devices can be licensed or acquired. In this manner, Innovia maintains ownership of its proprietary biomaterials while benefiting from the success of the devices incorporating them. Further, by forming affiliates to house individual products in various sectors of the medical arena, i.e. ophthalmology, cardiovascular, orthopedics, etc., potential industry-specific buyers need only purchase the affiliate that serves their interests, and not a large company with a diverse array of multi-staged products.
Technology / Differentiation
Novel sealants for vascular grafts; polysaccharide derived biomaterials including biodegradable polymers, poly-SIBS (styrene-b-isobutylene-b-styrene) for bioimplants incuding ocular implants; synthetic valve technology. (SIBS is currently used in the Taxus stent.)
Market / Customers
Biopsy device; orbital tissue expander for ophthalmic aplications.